Liposomal polyethyleneglycol and polyethyleneglycol-peptide combinations for active targeting to liver in vivo

Drug Delivery

Volumn 15, Issue 4, 2008, Pages 207-217

  Haynes, Sherry M ^a   Longmuir, Kenneth J ^a   Robertson, Richard T ^a   Baratta, Janie L ^a   Waring, Alan J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug delivery; Liposome; Liver targeting; Plasmodium; Polyethyleneglycol

Indexed keywords

CALCEIN; CIRCUMSPOROZOITE PROTEIN; LIPOSOME; MACROGOL 3400; MACROGOL 5000; MACROGOL DERIVATIVE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PROPYLAMINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG FORMULATION; DRUG SCREENING; DRUG TARGETING; FEMALE; HEART MUSCLE CELL; KIDNEY CELL; LIVER; LIVER CELL CULTURE; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; COST-BENEFIT ANALYSIS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; INJECTIONS, INTRAVENOUS; LIPOSOMES; LIVER; MICE; MICE, INBRED BALB C; PHOSPHATIDYLCHOLINES; PLASMODIUM BERGHEI; POLYETHYLENE GLYCOLS; PROTOZOAN PROTEINS; TISSUE DISTRIBUTION;

EID: 43049141214     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802006211     Document Type: Article

References (32)

1. Abraham, S. A., Waterhouse, D. N., Mayer, L. D., Cullis, P. R., Madden, T. D., and Bally, M. B. 2005. The liposomal formulation of doxorubicin. Methods Enzymol. 391:71-97.
2. Allen, T. M., and Martin, F. J. 2004. Advantages of liposomal delivery systems for anthracyclines. Semin. Oncol. 31:5-15.
3. Ancsin, J. B., and Kisilevsky, R. A. 2004. Binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein: Significance for malarial sporozoite attachment to hepatocytes. J. Biol. Chem. 279:21824-21832.
4. Barratt, G. 2003. Colloidal drug carriers: Achievements and perspectives. Cell. Mol. Life Sci. 60:21-37.
5. Beavis, R. C., Chaudhary, T., and Chait, B. 1992. Alpha-cyano-4- hydroxycinnamic acid as a matrix for matrix-assisted laser desorption massspectrometry. Org. Mass Spectrom. 27:156-158.
6. Bligh, E. G., and Dyer, W. J. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
7. Cevc, G. 1993. Phospholipids Handbook. New York: Marcel Dekker Inc., 946.
8. Charrois, G. J. R., and Allen, T. M. 2004. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim. Biophys. Acta 1663:167-177.
9. Eliaz, R. E., Nir, S., and Szoka, F. C. 2004. Interactions of hyaluronan-targeted liposomes with cultured cells: Modeling of binding and endocytosis. Methods Enzymol. 387:16-33.
10. Fields, C. G., Lloyd, D. H., Macdonald, R. L., Otteson, K. M., and Noble, R. L. 1991. HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res. 4:95-101.
11. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., and Zalipsky, S. 1999. Targeting folate receptor with folate linked to extremities of poly(ethyleneglycol)-grafted liposomes: In vitro studies. Bioconj. Chem. 10:289-298.
12. Gabizon, A. 2003. Emerging role of liposomal drug carrier systems in cancer chemotherapy. J. Liposome Res. 13:17-20.
13. Gabizon, A., Shmeeda, H., Horowitz, A. T., and Zalipsky, S. 2004. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv. Drug Deliv. Rev. 56:1177-1192.
14. Guy, C. A., and Fields, G. B. 1997. Trifluoroacetic acid cleavage and deprotection of resin-bound peptides following synthesis by Fmoc chemistry. Methods Enzymol. 289:67-83.
15. Lakowicz, J. R. 1999. Principles of Fluorescence Spectroscopy, 2nd ed. New York: Kluwer Academic/Plenum Publishers, 54.
16. Longmuir, K. J., Robertson, R. T., Haynes, S. M., Baratta, J. L., and Waring, A. J. 2006. Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence. Pharm. Res. 23:759-769.
17. Lyon, M., Deakin, J. A., and Gallagher, J. T. 1994. Liver heparan sulfate structure. A novel molecular design. J. Biol. Chem. 269:11208-11215.
18. Marcucci, F., and Lefoulon, F. F. 2004. Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress. Drug Discov. Today 9:219-228.
19. Maruyama, K. 2002. PEG-immunoliposome. Biosci. Rep. 22:251-266.
20. Ménard, R. 2000. The journey of the malaria sporozoite through its hosts: Two parasite proteins lead the way. Microbes Infect. 2:633-642.
21. Moghimi, S. M., and Szebeni, J. 2003. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42:463-478.
22. Mota, M. M., and Rodriguez, A. 2002. Invasion of mammalian host cells by Plasmodium sporozoites. Bioessays 24:149-156.
23. Otera, J. 2003. Esterification: Methods, Reactions, and Applications. Weinheim: Wiley-VCH.
24. Park, Y. S. 2002. Tumor-directed targeting of liposomes. Biosci. Rep. 22:267-281.
25. Pinzon-Ortiz, C., Friedman, J., Esko, J., and Sinnis, P. 2001. The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for Plasmodium sporozoite attachment to target cells. J. Biol. Chem. 276:26784-27791.
26. Pradel, G., Garapaty, S., and Frevert, U. 2002. Proteoglycans mediate malaria sporozoite targeting to the liver. Mol Microbiol. 45:637-651.
27. Sapra, P., and Allen, T. M. 2003. Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42:439-462.
28. Sato, R., Itabashi, Y., Fuhishima, H., Okuyama, H., and Kuksis, A. 2004. Simple synthesis of diastereomerically pure phosphatidylglycerols by phospholipase D-catalyzed transphosphatidylation. Lipids 39:1025-1030.
29. Shin, S. C., Vanderberg, J. P., and Terzakis, J. A. 1982. Direct infection of hepatocytes by sporozoites of Plasmodium berghei. J. Protozool. 29:448-454.
30. Soroka, C. J., and Farquar, M. G. 1991. Characterization of a novel heparan sulfate proteoglycan found in the extracellular matix of liver sinusoids and basement membranes. J. Cell Biol. 113:1231-1241.
31. Tewari, R., Spaccepelo, R., Bistoni, F., Holder, A. A., and Crisanti, A. 2002. Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity. J. Biol. Chem. 277:47613-47618.
32. Ungureanu, E., Killick-Kendrick, R., Garnham, P. C., Branzie, P., Romanescu, C., and Shute, P. G. 1977. Prepatent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites. Trans. R. Soc. Trop. Med. Hyg. 70:482-483.